Skip Navigation
Skip to contents

ICDM 2025

D--13 TODAY.
2025-10-08
Menu Close

Program details

Home

Program
Program details

Menu View

Special interest sessions
Special interest session (K) Artificial intelligence, the humanities, and medicine
(인공지능, 인문학, 그리고 의료) Chair(s): Kyoil Suh, Sin Gon Kim
Thursday 25 September, 16:30~17:50
Room 1
(Vista 1+2, B2F)
The emergence of artificial intelligence (AI) marks a pivotal turning point in human civilization. As highlighted by the recipients of the 2024 Nobel Prizes in Physics and Chemistry, the pace of AI advancement is surpassing expectations across scientific disciplines. But should we greet this progress with unreserved optimism? In this special session, two of Korea’s most esteemed scholars will offer deep reflections on the AI era from a humanities-based perspective. Their lectures will examine how humanity is preparing for the societal transformations driven by AI and explore the evolving identity and purpose of medical professionals in this new landscape. Following the presentations, a 20-minute panel discussion with AI experts will further explore the future of human–AI coexistence and the shifting roles of healthcare professionals. Simultaneous AI-powered interpretation will be available in 37 languages.
인공지능(AI)의 급속한 발전은 인류 문명의 새로운 전환점을 예고하고 있다. 2024년 노벨 물리학상과 화학상 수상이 보여주듯, AI 기술의 진보는 우리의 예상을 뛰어넘는 속도로 진행되고 있다. 그러나 이러한 발전을 마냥 낙관적으로만 바라보아도 될까? 이번 특별 세션에서는 대한민국을 대표하는 두 석학을 모시고, 인공지능 시대를 인문학적 관점에서 깊이 있게 성찰하고자 한다. 인류가 어떤 준비를 해야 하는지, 그리고 변화하는 시대 속에서 의료전문가는 어떤 역할을 수행하게 될지를 고찰하는 시간이 될 것이다. 각 30분 강연에 이어, AI 전문가 패널과 함께 20분간의 토론이 진행된다. 또한, 인공지능 기반 동시통역 시스템을 통해 총 37개국 언어로 실시간 통역이 제공될 예정이다.
Sang Wook Yi SIS1-L1
Sang Wook YiHanyang University, Korea
Reconsidering humanity in the age of AI
(인공지능 시대, 인간을 다시 생각한다)
Wootaek Jeon SIS1-L2
Wootaek JeonYonsei University, Korea
The AI era in medicine: key questions and future roles
(인공지능 시대 속의 의료: 우리가 하여 할 질문과 역할)
AI Panel SIS1-P1
AI PanelKDA, Korea
Panel discussion
Hot publication debate session COMBINE 1, ACHIEVE 1 and CONFIDENCE trials Chair(s): Jeong Hyun Park, Gwanpyo Koh
Saturday 27 September, 08:40~10:00
Room 1
(Vista 1+2, B2F)
This session reviews key research papers published in the field of diabetes and metabolic diseases over the past year. The selected papers include the ACHIEVE1 trial, which examines the glucose lowering efficacy of orforglipron in type 2 diabetes patients, a phase 3a trial on the efficacy of once‑weekly IcoSema (COMBINE1 trial), and the CONFIDENCE trial, which examined the effects of finerenone plus empagliflozin on albuminuria in patients with both chronic kidney disease and type 2 diabetes. The session aims to critically analyze the results, significance, and limitations of each study, providing a comprehensive overview of the latest research trends in diabetes and metabolic diseases.
Hyun Ah Kim SIS3-L1
Hyun Ah KimVeterans Health Service Medical Center, Korea
Orforglipron, an oral small-molecule GLP-1 receptor agonist, in early type 2 diabetes: a review of the ACHIEVE-1 trial
Young Min Cho SIS3-L2
Young Min ChoSeoul National University, Korea
Discussion on ACHIEVE-1 study
Yu Ji Kim SIS3-L3
Yu Ji KimJeonbuk National University, Korea
Once-weekly IcoSema versus once-weekly insulin icodec in type 2 diabetes management (COMBINE 1): a randomized, open-label, phase 3a trial
Linong Ji SIS3-L4
Linong JiPeking University, China
All about COMBINE 1 trial
Inha Jung SIS3-L5
Inha JungKorea University , Korea
Finerenone with empagliflozin in chronic kidney disease and type 2 diabetes
Jennifer B. Green SIS3-L6
Jennifer B. GreenDuke University, USA
Clinical importance of the CONFIDENCE trial
Year in review and perspective Chair(s): Soon Jib Yoo, Chul-Hee Kim
Saturday 27 September, 16:00~17:00
Room 1
(Vista 1+2, B2F)
This session highlights important research findings in diabetes and its management over the past year, with insights from leading experts. Speakers will provide a critical overview of recent developments and offer perspectives on key directions for future research.
Jae Hyeon Kim SIS6-L1
Jae Hyeon KimSungkyunkwan University, Korea
Technology-driven monitoring and management
Soo Lim SIS6-L2
Soo LimSeoul National University, Korea
Redefining obesity: translational insights and future challenges
Sin Gon Kim SIS6-L3
Sin Gon KimKorea University, Korea
Cardio-renal-metabolic breakthroughs: landmark trials shaping the future
The great talk: ask us anything (K) Chair(s): Sin Gon Kim, Junghyun Noh
Saturday 27 September, 13:10~14:30
Room 3
(Walker hall 1, 1F)
The great talk special session has invited esteemed professors who have dedicated more than 30 years of their careers to the field of diabetology. These distinguished professors have played a pivotal role in shaping discipline and have a wealth of knowledge and experience to share. This exclusive event provides a unique opportunity for future generations of diabetologists to learn from the insights and wisdom of these seasoned professionals. Attendees will gain valuable perspectives on successful careers in diabetology and immerse themselves in the remarkable journeys of their esteemed seniors.
The great talk 특별 세션에서는 내분비 인생의 길을 30여년 이상 걸어오신 인생의 선배이자 이 분야를 선도해 오신 교수들을 모시고, 다양한 경험과 의사이자 학자, 그리고 교육자로서 소중한 지혜를 미래 세대에 전수할 수 있는 장을 마련했다. 인생 선배들의 여정에 빠져들어 그분들의 통찰력에서 배우며 내분비학자로서 성공적인 삶을 엿보는 기회가 될 것이다.
Kyung Soo Ko SIS4-L1
Kyung Soo KoInje University, Korea
Long journey to the patients, still going
(내분비내과 교수의 긴 여정)
Tae Sun Park SIS4-L2
Tae Sun ParkJeonbuk National Univeristy, Korea
My decision to diabetes as a professor
(교수로서 당뇨병에 대한 나의 결정)
Special breakfast symposium (K) Heritage and future hope of KDA Chair(s): Young Seol Kim, Bong-Soo Cha
Saturday 27 September, 08:00~09:00
Room 6~7
(Grand hall 4~5, B1F)
In 2028, the Korean Diabetes Association (KDA) will celebrate its 60th anniversary. Starting from humble beginnings 57 years ago, the KDA has grown into an organization of 4,000 members thanks to the devoted efforts of its pioneers and senior members. As it reaches this 60-year milestone, the KDA is preparing to become a world leader in diabetes research and care with global standards. This session will look back at the KDA's history, cast a vision for its future, and allow members to solidify their own visions through the experience and wisdom of their seniors.
2028년, 대한당뇨병학회(KDA)는 창립 60주년을 맞이합니다. 57년 전, 불모지에서 시작된 KDA는 선각자들과 선배 회원들의 헌신적인 노력으로 현재 4,000명 규모의 학회로 성장했습니다. 60주년을 기점으로, KDA는 당뇨병 연구 및 치료 분야에서 글로벌 표준을 제시하는 리더로 도약할 준비를 하고 있습니다. 본 세션에서는 KDA의 역사를 되짚어보고 미래를 조망하며, 선배들의 경험과 지혜를 통해 후학들의 비전을 다지는 자리가 될 것입니다.
Hyung Joon Yoo SIS2-L1
Hyung Joon YooCM Hospital, Korea
KDA, our heritage, our pride
(KDA, 우리 유산, 우리 자랑)
Sin Gon Kim SIS2-L2
Sin Gon KimKorea University, Korea
From legacy to innovation: KDA’s vision for the future of diabetes
(법고창신 - KDA의 현재와 미래 비전)
Panel discussion
  • Dong Seop Choi SIS2-P1
    Dong Seop ChoiGovernment Complex Gwacheon Clinic, Korea
  • Moon-Kyu Lee SIS2-P2
    Moon-Kyu LeeEulji University, Korea
  • Kyu Jeung Ahn SIS2-P3
    Kyu Jeung AhnKyung Hee University, Korea
  • Sungrae Kim SIS2-P4
    Sungrae KimThe Catholic University of Korea, Korea
Young diabetologist boot camp (K) Real talk for future diabetologists and medical students Chair(s): Byung Joon Kim, Nam Hoon Kim
Saturday 27 September, 14:40~16:00
Room 6~7
(Grand hall 4~5, B1F)
This session is designed to highlight the academic appeal of diabetes and metabolic diseases while providing a solid foundation in their core concepts. Topics will include the physiological mechanisms of normal glucose regulation and the pathophysiology of diabetes, the role of GLP-1 and the history of therapeutic development that has recently become a major societal focus, and the evolving role of endocrinology in the era of artificial intelligence. We look forward to an engaging and inspiring learning experience.
이번 ICDM에서는 의대생과 전공의를 위한 특별 세션을 준비했습니다. 당뇨병과 대사질환의 학문적 매력을 느끼고 기본 개념을 익힐 수 있도록 구성된 강의들로 이루어져 있습니다. 정상 혈당 조절의 생리적 메커니즘과 이를 벗어난 병태생리로서의 당뇨병 개념, 최근 사회적으로도 주목받고 있는 GLP-1의 역할과 치료제 개발의 역사, 그리고 다가오는 AI 시대 속에서 내분비학이 맡게 될 새로운 역할까지 폭넓게 다룹니다. 흥미롭고 배움이 가득한 시간이 될 것입니다.
Jae-Han Jeon SIS5-L1
Jae-Han JeonKyungpook National University, Korea
Principles of glucose regulation: from physiology and pathology
(혈당 조절의 원리와 당뇨병 이환의 병태생리)
Tae Jung Oh SIS5-L2
Tae Jung OhSeoul National University, Korea
Incretin-based therapies: from diabetes to obesity management (당뇨병 치료에서 비만 치료까지: 인크레틴의 역할)
Sin Gon Kim SIS5-L3
Sin Gon KimKorea University, Korea
An AI Odyssey: preparing for the future of diabetes care (AI 오디세이: 당뇨병 치료의 미래와 우리의 준비)
KDA 대한당뇨병학회Korean Diabetes Association
  • (04146) 101-2104, Lotte Castle President, 109 Mapo-gu, Seoul, Korea
  • Tel: +82-2-714-9064 | E-mail: diabetes@kams.or.kr
  • Business Registration Number: 106-82-31108 | Name of Representative: Bong-Soo Cha
Congress Secretariat (Planbear)
  • #1108, 220, Gonghang-daero, Gangseo-gu, Seoul(07806), Republic of Korea
  • Tel. +82-2-6953-0582   E-mail: icdm@diabetes.or.kr

copyright© By Korean Diabetes Association.
All rights reserved.
Business Registration Number: 106-82-31108
Name of Representative : Bong-Soo Cha